Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Feb 5;100(5):e23693.
doi: 10.1097/MD.0000000000023693.

Effects of clinicopathological factors on prognosis of young patients with resected breast cancer

Affiliations
Observational Study

Effects of clinicopathological factors on prognosis of young patients with resected breast cancer

Wen Li et al. Medicine (Baltimore). .

Abstract

This study aims to analyze the relationship between clinicopathological characteristics and survival in young patients (≤35 years old) with resected breast cancer.A total of 173 cases were included in this study. The clinicopathological factors potentially associated with prognosis were evaluated. Furthermore, we categorized patients into different groups to evaluate the prognosis according to hormone receptor status or important risk factors.Younger age (≤30 years) was an independent predictor for poor disease-free survival (DFS) and overall survival (OS). Besides, PR negative status, tumor grade, and advanced lymph nodes postsurgery were independent prognostic factors of DFS, while PR negative status and advanced lymph nodes postsurgery were independent prognostic factors of OS. For hormone receptor-positive patients, people with ER+ or PR+ and HER2-/+ showed poorer prognosis than the other 2 levels. Risk factor grouping based on the ER, PR, HER2, Ki-67 status, tumor grade, and lymph nodes postsurgery showed that patients in highest score group received the poorest prognosis. Grading system based on the hormone status or the risk factor grouping may offer a useful approach to assess which subgroups of young breast cancer present poorer prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interests to disclose.

Figures

Figure 1
Figure 1
Kaplan-Meier survival analyses of correlations between age and survival among breast cancer patients: DFS (A) and OS (B).
Figure 2
Figure 2
ER, PR, HER2 status and survival. Kaplan–Meier survival analysis on DFS (A) in accordance with ER, PR, and HER2 status. Kaplan–Meier survival analysis on OS (B) in accordance with ER, PR, and HER2 status.
Figure 3
Figure 3
Risk factor grouping and survival: DFS by Kaplan–Meier survival analysis (A) in accordance with risk factor grouping. OS by Kaplan–Meier survival analysis (B) in accordance with risk factor grouping.

Similar articles

Cited by

References

    1. Wu J, Xue X, Zhang B, et al. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer. Tumour Biol 2016;37:12301–13. - PubMed
    1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA 2015;65:87–108. - PubMed
    1. Zhao Y, Dong X, Li R, et al. Correlation between clinical-pathologic factors and long-term follow-up in young breast cancer patients. Transl Oncol 2015;8:265–72. - PMC - PubMed
    1. Chen HL, Ding A, Wang FW. Prognostic effect analysis of molecular subtype on young breast cancer patients. Chin J Cancer Res 2015;27:428–36. - PMC - PubMed
    1. Azim HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res 2014;16:427. - PMC - PubMed

Publication types